Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift. - Wikidata - wikimedia - TriplyDB

Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.

Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.

http://www.wikidata.org/entity/Q36796216

about

The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial.Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.Uremic Toxicity of Advanced Glycation End Products in CKD.Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease.Effect of diet-derived advanced glycation end products on inflammation.Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse.Skeletal muscle ceramide species in men with abdominal obesity.Sevelamer reduces endothelial inflammatory response to advanced glycation end products.Mediterranean Diet Supplemented With Coenzyme Q10 Modulates the Postprandial Metabolism of Advanced Glycation End Products in Elderly Men and Women.Gene therapy in peripheral artery disease Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice

P2860

Q34311324-3EF2AD8A-FA0A-4DE7-ABFB-32E5898AE679 Q35194026-0F83DECC-2C7E-495E-A3B2-801BC88A3C64 Q35576119-6A7AE05F-642A-4307-A756-79E8B1DE21EB Q35618768-DA37D0F2-F680-4DC1-90F0-7FF629572C63 Q36514906-617A1BC2-503B-44D6-8A19-DA2DD3B282D2 Q37567574-EAF3ACE7-E01E-4C8D-B33C-840510394933 Q38206090-43390969-2BCA-4E73-BF94-7ECE4AF6B32A Q38588208-71BE3936-23C3-44A9-B905-D734CEEF718C Q43876702-4092FEC9-DA8D-44C3-9D04-2EA5555A0CBE Q46753548-22C70874-CF23-4B53-9047-28227F596EF2 Q48505037-E78F6E46-52FC-49F7-A4ED-5975654A3D2C Q52891782-B38DE281-6308-49F0-9400-2FAD3C218725 Q58362653-40A3B935-A166-4859-B42D-65E4B9788A58 Q58699291-5AD93ECA-CC4E-41E1-ADF1-B4388B0AF0DD

P2860

Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.

http://www.wikidata.org/entity/Q36796216

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Managing chronic inflammation ...... nate: a modern paradigm shift.

@en

type

label

Managing chronic inflammation ...... nate: a modern paradigm shift.

@en

prefLabel

Managing chronic inflammation ...... nate: a modern paradigm shift.

@en

P1433

Q36796216-6EDB63D5-8ABB-4727-8E1E-3C6ECA75F13E

P1476

Q36796216-CFC012D0-78BA-4C53-8747-C95DD74E75A6

P2093

Q36796216-39CBFBCD-ECE8-46D8-8137-CE834252B9D4

Q36796216-6E76C0CE-5A7B-47BA-A2E9-0710026F6114

Q36796216-8CD9CF62-5F2B-4371-95CE-E4B147042C7A

Q36796216-99F79C08-F937-4580-82D3-F097DBEB114C

Q36796216-AC8867C0-6E30-4943-90D6-F9B200487A81

Q36796216-AFC76BF4-F2BE-4BF2-B1CA-BB6F7AE8502C

Q36796216-B7494331-6E85-4A6E-B997-FE4BFADE6D53

Q36796216-E309BDDA-09CA-4059-BD04-5C23F995B359

P2860

Q36796216-004778EF-DDDA-4171-B66D-3BC436D1AAAD

Q36796216-08EE7268-9A42-4935-A20D-AD33C4456497

Q36796216-0D0E58FD-37CD-45DC-8DCD-2E3CC6A7832B

Q36796216-0D9C58CC-6152-4274-817F-517092CA3638

Q36796216-14D9AA3F-ED03-4E79-AE13-FC462274F18F

Q36796216-19854581-272A-460A-A435-1B0B155443FD

Q36796216-1EC5EF1E-67A7-40CD-9006-08AFD3C3B166

Q36796216-22FE8717-A5EE-4E4C-8A7E-42492F7A5DC1

Q36796216-2473700B-9F8B-44C1-9235-4E4C1BB830B9

Q36796216-2C7A2A4D-1FE0-4989-B9AF-CBC388D3A804

P304

Q36796216-4AD4BF23-D38E-42C3-99B2-8F855F169E1D

P31

Q36796216-6C452623-3238-4BD5-9FD6-D13DD91D11B5

P356

Q36796216-F2A12690-DB87-4701-A1B2-5645D5197EED

P407

Q36796216-C7AD5391-D42E-4113-BD2C-8FF1563FEE03

P433

Q36796216-79FCB226-B1E2-4F5C-98E2-90F8A7BD5C93

P478

Q36796216-E4171378-EEB0-4876-9808-A8320B5EABC1

P577

Q36796216-9778F18B-05ED-4370-B32B-1736DAC8539C

P5875

Q36796216-CA1B3DB1-3A88-4513-87DA-CCF294F95C36

P698

Q36796216-06527657-2F0C-44BA-9737-1677F47D220E

P932

Q36796216-1F45D606-0B61-46D2-9850-22A95E14A2C4

P356

P1433

The Journals of Gerontology

P1476

Managing chronic inflammation ...... nate: a modern paradigm shift.

@en

P2093

E J Serrano

http://www.w3.org/2001/XMLSchema#string

G E Striker

http://www.w3.org/2001/XMLSchema#string

H Vlassara

http://www.w3.org/2001/XMLSchema#string

J Uribarri

http://www.w3.org/2001/XMLSchema#string

M S Shobha

http://www.w3.org/2001/XMLSchema#string

M Woodward

http://www.w3.org/2001/XMLSchema#string

W Cai

http://www.w3.org/2001/XMLSchema#string

X Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes

Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE

Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline

AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.

Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms

Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation

P304

1410-1416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GERONA/GLS195

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232739453

http://www.w3.org/2001/XMLSchema#string

P698

23109677

http://www.w3.org/2001/XMLSchema#string

P932

3636675

http://www.w3.org/2001/XMLSchema#string